Tornyi Ilona, Horváth Ildikó
Department of Pulmonology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
National Koranyi Institute of Pulmonology, 1121 Budapest, Hungary.
J Clin Med. 2024 May 22;13(11):3044. doi: 10.3390/jcm13113044.
Asthma is a chronic inflammatory airway disease characterized by recurrent symptoms in response to a wide range of external stimuli, including allergens, viral infections, and air pollution together with internal host-derived danger signals. The disease is traditionally associated with adaptive immune responses; recent research emphasizes the critical role of innate immunity in its pathogenesis. The complement system, activated as part of the defense mechanisms, plays a crucial role in bridging innate to adaptive immunity. While experimental models demonstrate complement cascade activation in asthma, human studies remain limited. This systematic review summarizes existing literature on the complement system in asthma patients, gathering data from PubMed, Web of Science, Scopus, and Google Scholar. The protocol was registered in the OSF. Out of 482 initially identified articles, only 24 met the eligibility criteria, revealing disparities in sample origin, methodologies, and populations. Despite observed heterogeneity, a consistent result was found in the elevation of complement regulatory proteins, such as complement Factor H, in samples from patients with asthma compared to those from healthy subjects. The increased level of regulatory proteins, such as Factor H and I highlight that these may influence asthma pathophysiology. The role of complement factors as potential biomarkers of asthma activity and severity needs further evaluation.
哮喘是一种慢性炎症性气道疾病,其特征为对多种外部刺激(包括过敏原、病毒感染、空气污染以及内源性宿主危险信号)产生复发性症状。传统上,该疾病与适应性免疫反应相关;最近的研究强调了固有免疫在其发病机制中的关键作用。作为防御机制一部分而被激活的补体系统,在连接固有免疫和适应性免疫方面起着至关重要的作用。虽然实验模型表明哮喘中补体级联反应被激活,但人体研究仍然有限。本系统综述总结了关于哮喘患者补体系统的现有文献,从PubMed、科学网、Scopus和谷歌学术收集数据。该方案已在开放科学框架(OSF)注册。在最初识别出的482篇文章中,只有24篇符合纳入标准,这揭示了样本来源、方法和人群方面的差异。尽管观察到存在异质性,但与健康受试者相比,哮喘患者样本中补体调节蛋白(如补体因子H)升高这一结果是一致的。诸如因子H和I等调节蛋白水平的升高表明,这些蛋白可能影响哮喘的病理生理学。补体因子作为哮喘活动和严重程度潜在生物标志物的作用需要进一步评估。